UWM (UWMC) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
21 Oct, 2026Strategic direction and 2030 goals
Strategy shifts toward broker-channel leadership balanced with profitability, returns, capital efficiency, cash generation and disciplined leverage.
2030 goals include 50%+ wholesale market share, 30%+ Adjusted EBITDA margin, 1.5x net non-funding debt-to-equity and a $0 preferred equity balance.
Broker-channel loan originations target 3+/10; targets are forward-looking goals subject to business, economic and competitive uncertainties.
Common dividends are suspended to retain capital and support growth and capital-structure flexibility.
Broker-channel growth and earnings model
Broker share of direct funded volume rose from 19.7% in 2022 to 28.1% LTM 2Q'26.
The wholesale platform is positioned to benefit across rate cycles: refinance-driven origination in low-rate markets and servicing income and MSR value in high-rate markets.
2025 Adjusted EBITDA was $697.3M with a 22% margin; 1H'26 was $346.8M with a 10% margin.
Operating expenses were 0.9% of LTM originations; most incremental costs are production-linked, with existing fixed-cost capacity supporting higher volume.
Capital strategy and balance sheet
Pro forma net non-funding debt-to-equity is 1.2x versus 5.6x at 2Q26; pro forma equity is $3.0B versus $985M.
Pro forma available liquidity is $2.681B versus $1.056B at 2Q26; figures assume the preferred investment and rights offering, $500M minimum cash and $35M transaction expenses.
Capital plan combines retained earnings, potential warrant exercise proceeds and refinancing capacity to reduce preferred without depending on a major mortgage-market recovery.
Opportunistic MSR sales, debt repayment and equity capital are among the tools to strengthen liquidity while maintaining leverage below the 2.0x threshold.
Latest events from UWM
- Q3 profit recovered, while lower originations and rate-sensitive valuations persisted.UWMC
Q3 2026 - Preliminary 3Q26 earnings and planned MSR sales underpin a debt-paydown effort.UWMC
Investor presentation - Q2 2026 saw $39.7B in originations, a $451.9M net loss, and a $1.65B capital infusion.UWMC
Q2 2026 - Q3 originations hit $41.7B; Adjusted EBITDA reached $211.1M as net income fell year over year.UWMC
Q3 2025 - Q2 delivered $39.7B in production and $314.5M in net income; Q3 margin guidance rose.UWMC
Q2 2025 - Q3 originations reached $39.5B as MSR valuation declines weighed on net income.UWMC
Q3 2024 - Production rose to $33.6B as net income reached $76.286M despite MSR fair-value pressure.UWMC
Q2 2024 - Q1 originations rose 17.1% to $32.4B, while MSR losses drove a $247M net loss.UWMC
Q1 2025 - Record $96.1B purchase production and $329.4M net income in 2024.UWMC
Q4 2024